SAT0436 Durability of apremilast response in patients with psoriatic arthritis: long-term (208-week) results from the palace 1 trial

Arthur Kavanaugh, J. Wollenhaupt, JJ Gómez-Reino et al.|Annals of the Rheumatic Diseases|2017

Cited by 0